Not finding it? Sign in to also search OpenAlex live.
-
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study
Fatemeh Saberi Hosnijeh, Lina van der Straten, Arnon Philip Kater, Marinus H. J. van Oers, Ward F.M. Posthuma, Martine E.D. Chamuleau, +16 more
8citations -
Venetoclax May Overcome the Prognostic Disadvantage of Short Telomeres Regarding Progression Free Survival in Previously Untreated CLL Patients with Coexisting Conditions: A Study By the German CLL Study Group (GCLLSG)
Lukas Peter Frenzel, Laura Beckmann, Sandra Robrecht, Anna Maria Fink, Othman Al‐Sawaf, Christof Schneider, +9 more
0citations -
Seven-Day Vein-to-Vein Point-of-Care Manufactured CD19 CAR T Cells (GLPG5201) in Relapsed/Refractory CLL/SLL Including Richter's Transformation: Results from the Phase 1 Euplagia-1 Trial
Natalia Tovar, Valentín Ortiz‐Maldonado, Núria Martínez‐Cibrián, Sergi Betriu, Daniel Esteban, Ana Triguero, +5 more
5citations
6 results